Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: a study of bortezomib and thalidomide.

× No keyword cloud information.

4 in total

1. Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma.

Authors: Xiao Gao; Chunming Li; Run Zhang; Ruifang Yang; Xiaoyan Qu; Hairong Qiu; Jiaren Xu; Hua Lu; Jianyong Li; Lijuan Chen
Journal: Med Oncol Date: 2011-05-25 Impact factor: 3.064

2. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

Authors: S Vincent Rajkumar; Jean-Luc Harousseau; Brian Durie; Kenneth C Anderson; Meletios Dimopoulos; Robert Kyle; Joan Blade; Paul Richardson; Robert Orlowski; David Siegel; Sundar Jagannath; Thierry Facon; Hervé Avet-Loiseau; Sagar Lonial; Antonio Palumbo; Jeffrey Zonder; Heinz Ludwig; David Vesole; Orhan Sezer; Nikhil C Munshi; Jesus San Miguel
Journal: Blood Date: 2011-02-03 Impact factor: 22.113

Review 3. Treatment strategies in elderly patients with multiple myeloma: current status.

Authors: Hang Quach; H Miles Prince; Linda Mileshkin
Journal: Drugs Aging Date: 2007 Impact factor: 3.923

4. The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population.

Authors: Wenjun Yu; Rui Guo; Xiaoyan Qu; Hairong Qiu; Jianyong Li; Run Zhang; Lijuan Chen
Journal: Onco Targets Ther Date: 2016-01-12 Impact factor: 4.147

4 in total